Anik Chaturbedi

United States Food and Drug Administration

Also affiliated with Center for Drug Evaluation and Research

MedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Toward Developing Alternative Opioid Antagonists for Treating Community Overdose: A Model‐Based Evaluation of Important Pharmacological Attributes”.

Toward Developing Alternative Opioid Antagonists for Treating Community Overdose: A Model‐Based Evaluation of Important Pharmacological Attributes

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3527

N/A

0DataRank · unranked

6 citations

John Mann, Shilpa Chakravartula, Bradlee Thrasher, Ghazal Arabidarrehdor, Joel Zirkle +5 more

Reply to “Translational Modeling as a Tool to Evaluate the Effectiveness of Nalmefene in a Community Setting: A Critical Perspective”

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3669

N/A

0DataRank · unranked

0 citations

Anik Chaturbedi, Shilpa Chakravartula, John Mann, Seyed Hamed Meshkin, Jeffry Florian +1 more